Moderna, Inc.
MRNA
$26.26
-$0.46-1.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 86.00M | 938.00M | 1.82B | 184.00M | 167.00M |
| Total Other Revenue | 22.00M | 28.00M | 42.00M | 57.00M | -- |
| Total Revenue | 108.00M | 966.00M | 1.86B | 241.00M | 167.00M |
| Cost of Revenue | 946.00M | 1.86B | 1.65B | 1.34B | 1.16B |
| Gross Profit | -838.00M | -895.00M | 211.00M | -1.10B | -992.00M |
| SG&A Expenses | 212.00M | 351.00M | 281.00M | 268.00M | 274.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.16B | 2.21B | 1.93B | 1.60B | 1.43B |
| Operating Income | -1.05B | -1.25B | -70.00M | -1.36B | -1.27B |
| Income Before Tax | -964.00M | -1.18B | 21.00M | -1.28B | -1.17B |
| Income Tax Expenses | 7.00M | -64.00M | 8.00M | -- | 10.00M |
| Earnings from Continuing Operations | -971.00M | -1.12B | 13.00M | -1.28B | -1.18B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -971.00M | -1.12B | 13.00M | -1.28B | -1.18B |
| EBIT | -1.05B | -1.25B | -70.00M | -1.36B | -1.27B |
| EBITDA | -1.01B | -1.19B | -18.00M | -1.32B | -1.23B |
| EPS Basic | -2.52 | -2.91 | 0.03 | -3.33 | -3.08 |
| Normalized Basic EPS | -1.55 | -1.91 | 0.05 | -2.04 | -1.88 |
| EPS Diluted | -2.52 | -2.92 | 0.03 | -3.33 | -3.08 |
| Normalized Diluted EPS | -1.55 | -1.91 | 0.05 | -2.04 | -1.88 |
| Average Basic Shares Outstanding | 386.00M | 385.00M | 385.00M | 384.00M | 382.00M |
| Average Diluted Shares Outstanding | 386.00M | 385.00M | 399.00M | 384.00M | 382.00M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |